Clinical Trials Sponsored by Ascentia Health, Inc

Total 3273 results

Bausch Health Americas, Inc.

Completed

Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face

Acne Vulgaris

United States
Intermountain Health Care, Inc.

Terminated

Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy

Back Pain | Low Back Pain

United States
Integrative Health Technologies, Inc.

Completed

Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin (L-Arabinose)

Pre-diabetes

United States
Venous Health Systems, Inc.

Completed

Vasculaire Compression System Increases Flow Velocity in the Femoral Vein

Venous Thrombosis

United States
WellSpan Health
Hologic, Inc.

Completed

Efficacy of Tomosynthesis in the BIRADS 3 Population (BIRADS)

Breast Cancer
Northwell Health
Eisai Inc.

Completed

Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation

Epilepsy | Developmental Disabilities | Mental Retardation

United States
Intermountain Health Care, Inc.

Completed

SAFEstart Feeding Intolerance Study Phase II

Feeding Intolerance | Abdominal Distention | Gastric Residual | Emesis and Diarrhea | Blood in Stool

United States
Capital Health System, Inc

Recruiting

Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma

United States
Bausch Health Americas, Inc.

Recruiting

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

Psoriasis

United States
Bausch Health Americas, Inc.

Not yet recruiting

Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

Major Depressive Disorder

United States
Syntr Health Technologies, Inc.

Active, not recruiting

Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting

Facial Atrophy and Loss of Contour

United States
Bausch Health Americas, Inc.

Active, not recruiting

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3131)

Hepatic Encephalopathy

United States, Australia, Canada, Puerto Rico
Children's Health System, Inc.

Terminated

Iontophoresis With Dexamethasone and Physical Therapy to Treat Apophysitis of the Knee in Pediatrics

Apophysitis; Juvenile

United States
Northwell Health
HeartFlow, Inc.

Completed

The Value of CT Fractional Flow Reserve (VFFRCTA)

Angina, Stable Chest Pain
Bausch Health Americas, Inc.

Completed

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

Atopic Dermatitis

United States
Intermountain Health Care, Inc.

Active, not recruiting

Database Registry of the Intermountain Heart Collaborative Study

Coronary Artery Disease | Cardiovascular Disease | Electrophysiology

United States
Bausch Health Americas, Inc.

Completed

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

Onychomycosis

United States, Dominican Republic
RETINA-AI Health, Inc.

Completed

Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye Problems

United States
Medcura Inc.
Northwell Health

Completed

Randomized Study of Accelerated Radial Arterial Hemostasis (GOLOW)

Hemostasis

United States
Bausch Health Americas, Inc.

Completed

Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19

COVID19

Greece, Mexico
Bausch Health Americas, Inc.

Completed

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Bausch Health Americas, Inc.

Withdrawn

An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer

Pancreatic Cancer
Intermountain Health Care, Inc.

Terminated

PLUG Dementia Trial and MRI PLUG Dementia Sub-Study

Atrial Fibrillation | Dementia | Cognitive Decline

United States
Bausch Health Americas, Inc.

Completed

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)

Acne Vulgaris

United States, Canada
Bausch Health Americas, Inc.

Completed

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)

Acne Vulgaris

United States, Canada
Genomic Health®, Inc.

Terminated

Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer

Non Small Cell Lung Carcinoma

United States, Spain, Chile, France, Ireland, Japan, United Kingdom
United Health Products, Inc.

Completed

Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting

Bleeding | Hemostasis

United States
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Bausch Health Americas, Inc.

Completed

Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea

HIV Enteropathy | Diarrhea With HIV

United States
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

United States
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

Psoriasis

United States
EicOsis Human Health Inc.

Unknown

Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)

COVID-19

United States
Intermountain Health Care, Inc.

Completed

Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction (WONDERFUL)

Intermittent Fasting

United States
Intermountain Health Care, Inc.

Completed

Effect of Emergency Department Care Reorganization on Door-to-antibiotic Times for Sepsis (LDS SWARM)

Sepsis | Septic Shock

United States
Intermountain Health Care, Inc.

Completed

CGM - Reimagine Primary Care

Diabetes Mellitus, Type 2

United States
LifeBridge Health
Orthosensor, Inc.

Withdrawn

To Determine the Gait and Functional Improvement in Total Knee Arthroplasty (Orthosensor)

Degenerative Arthritis

United States
Intermountain Health Care, Inc.

Completed

I USE LR in the ED

Kidney Injury

United States
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

Plaque Psoriasis

United States
Bausch Health Americas, Inc.

Completed

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Acne

United States
Bausch Health Americas, Inc.

Completed

Silicone Hydrogel Soft Contact Lens 7-Day Extended Wear Basis

Myopia

United States
Bausch Health Americas, Inc.

Completed

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Acne

United States
Bausch Health Americas, Inc.

Withdrawn

Study Evaluating MOA-728 Administered in Healthy Men

Healthy
Bausch Health Americas, Inc.

Withdrawn

Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy

Methadone-maintenance Subjects

United States
Bausch Health Americas, Inc.

Completed

Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization

Healthy Volunteers

United States
Bausch Health Americas, Inc.

Completed

Tolerance and Pharmacokinetics Study of MNTX Tablets

Normal Healthy Volunteers

United States
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis

Tinea Corporis

Dominican Republic, Honduras
Bausch Health Americas, Inc.

Completed

Open-Label Treatment Extension of Protocol MNTX 302

Terminal Illness

United States
Bausch Health Americas, Inc.

Completed

Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

United States
Bausch Health Americas, Inc.

Completed

Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction

Bowel Dysfunction

United States
Bausch Health Americas, Inc.

Completed

Study Evaluating the Safety and Tolerability of a New Intravenous Formulation of MOA-728 in Healthy Subjects

Healthy

United States

3

Subscribe